Paasa Logo
ABIONYX Pharma S.A. logo
ABNXPARMarket openCloses 5:30pm CET

ABIONYX Pharma S.A.

€1.76Last updated
+€0.01 (0.34%)Past day
Timezone

ABIONYX Pharma S.A. (PAR: ABNX) is trading at €1.76, about ₹192 at today's EUR/INR rate, as of 30 Sep 2026, 7:44 AM ET, up 0.34% today. Indian residents can buy ABIONYX Pharma from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:€1.76
Previous close:€1.76
Volume:32.85K

Today's low

€1.74

Today's high

€1.79

52 week low

€1.66

52 week high

€5.29

ABNX opened at €1.76, closed previously at €1.76, and has traded between €1.66 and €5.29 over the past 52 weeks.

About

ABIONYX Pharma SA is a biotechnology company dedicated to the identification and advancement of therapies for conditions affecting the kidneys and eyes. The firm's pipeline includes CER-001, an innovative negatively-charged lipoprotein particle. This compound is designed to mimic the structural and functional attributes of pre-beta HDL, utilizing human recombinant apoA-I (a natural high-density lipoprotein protein) along with natural phospholipids like sphingomyelin and dipalmitoylphosphatidylglycerol. CER-001 is currently under development for patients recovering from acute coronary syndrome and those with familial primary hypoalphalipoproteinemia. Another key candidate, CER-002, is a specific agonist for peroxisome proliferator-activated receptor delta, targeting cardiovascular and metabolic diseases. Additionally, CER-209 is being developed as a potential treatment for metabolic liver diseases, atherosclerosis, and non-alcoholic steatohepatitis (NASH). ABIONYX maintains strategic partnerships with GTP Biologics and VBI Therapeutics Group for the bioproduction of its bio-HDL in France. Established in 2005, the company operated as Cerenis Therapeutics Holding SA before its rebranding to ABIONYX Pharma SA in August 2019. Its operations are headquartered in Balma, France.

Country
FR
CEO
Sir Cyrille Tupin
Exchange listed on
PAR
Industry
Biotechnology
Base currency
EUR
Full Time Employees
49
Sector
Healthcare
IPO date
30/03/2015

Key statistics

Avg. volume

166.66K

Market cap

€74.61M

P/E Ratio

-7.99

Price-to-sales ratio

19.24

Enterprise value

€134.86M

Free cash flow yield

-2.36%

Debt-to-equity ratio

0.97

Return on equity

-130.25%

ROIC

-65.53%

Beta

0.46

Dividend yield

0.00%

Last dividend

€0.00

Financial overview

Revenue

€4.06M

Earnings per share

-€0.16

Free cash flow

-€3.17M

Net profit margin

-207.84%

Gross margin

5.39%

EBITDA

-€5.70M

Revenue growth

-11.67%

Similar securities

This is not an investment recommendation

How to buy ABIONYX Pharma from India

Indian residents can buy ABIONYX Pharma shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.

  3. Search for ABIONYX Pharma and place an order

    Find ABIONYX Pharma by name or by its ticker, ABNX, and choose an order type. ABIONYX Pharma trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your ABIONYX Pharma position in EUR and INR. ABIONYX Pharma pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in ABIONYX Pharma from India

Trading and taxes when buying ABIONYX Pharma from India

Trading and limits

Trading hours
9:00 am – 5:30 pm CET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneABIONYX Pharma does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy ABIONYX Pharma stock?

Yes. ABIONYX Pharma (ABNX) has been listed on Euronext Paris since 2015, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one ABIONYX Pharma share cost in rupees?

One ABIONYX Pharma share is €1.76 — about ₹192 at an EUR/INR rate of 108.91 on 29 Sep 2026. Both the ABIONYX Pharma price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying ABIONYX Pharma from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on ABIONYX Pharma shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the ABIONYX Pharma price. Paasa issues a capital-gains statement for your return.

Does ABIONYX Pharma pay a dividend?

No. ABIONYX Pharma does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade ABIONYX Pharma from India?

Euronext Paris trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when France is on standard time. Orders can only execute during that window.

Do I have to declare ABIONYX Pharma shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your ABIONYX Pharma holding, its cost and its closing value.

How do I sell ABIONYX Pharma and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.

Does the rupee rate affect what I make on ABIONYX Pharma?

Yes. ABIONYX Pharma is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.